Results 71 to 80 of about 505,016 (285)

Lipoprotein (a) Testing in Patients With Atherosclerotic Cardiovascular Disease in 5 Large US Health Systems

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Lipoprotein (a) is an independent risk factor for atherosclerotic cardiovascular disease. However, lipoprotein (a) testing remains variable and it is unclear what factors influence testing and if testing changes clinical management.
Nishant P. Shah, Hillary Mulder, Elizabeth Lydon, Karen Chiswell, Xingdi Hu, Zachary Lampron, Lauren Cohen, Manesh R. Patel, Susan Taubes, Wenliang Song, Suresh R. Mulukutla, Anum Saeed, Daniel P. Morin, Steven M. Bradley, Adrian F. Hernandez, Neha J. Pagidipati   +15 more
doaj   +1 more source

Lipoprotein (a) levels in relation to severity of coronary artery disease in north Indian patients

Heart Views, 2013
Background: Lipoprotein (a) [Lp (a)] is an established risk marker of coronary artery disease which is independent from other risk factors. Objective: The aim was to address the association between Lp (a) and CAD risk in North Indians.
Fauzia Ashfaq, Pravin Kumar Goel, Rishi Sethi, Mohd Idrees Khan, Wahid Ali, Mohd Zafar Idris   +5 more
doaj   +1 more source

Control of Cholesterol Metabolism and Plasma High-Density Lipoprotein Levels by microRNA-144 [PDF]

, 2013
Cristina M. Ramírez, Noemí Rotllán, Alexander V. Vlassov, Alberto Dávalos, Mu Li, Leigh Goedeke, Juan Aranda, Daniel Cirera‐Salinas, Elisa Araldi, Alessandro G. Salerno, Amarylis Wanschel, Jiří Zavadil, Antonio Castrillo, Jungsu Kim, Yajaira Suárez, Carlos Fernández‐Hernando   +15 more
openalex   +1 more source

High‐Throughput In Vivo Screening Using Barcoded mRNA Identifies Lipid Nanoparticles With Extrahepatic Tropism for In Situ Immunoengineering

Advanced Materials, EarlyView.
A high‐throughput in vivo mRNA LNP screening platform is developed and employed to screen a large library of 122 mRNA LNPs in vivo for delivery to immune, stromal, and parenchymal cells, identifying promising LNP candidates. A novel small particle flow cytometry‐based protein adsorption analysis method is utilized to interrogate protein corona ...
Alex G. Hamilton, Ajay S. Thatte, Junchao Xu, Zhangyi Luo, Hannah C. Safford, Kelsey L. Swingle, Jenna Muscat‐Rivera, Michael Kegel, Xuexiang Han, Ryann A. Joseph, Amanda M. Murray, Hannah C. Geisler, Ricardo C. Whitaker, Lulu Xue, Roman Spektor, Jilian R. Melamed, Drew Weissman, Michael J. Mitchell   +17 more
wiley   +1 more source

Association of Butyryl Cholinesterase and Recurrent Ischemic Stroke: A Cross-Sectional Study

International Journal of General Medicine
Ruomeng Chen,1,2 Kun Zhang,1,2 Hui Liu,1,2 Lijuan Liu,1,2 Hui Li,3 Yan Yan,1,2 Zhou Zhou,1,2 Chaoyue Meng,1,2 Xuelin Wang,4 Haoran Wu,4 Ruihan Miao,4 Rui Wang,1,2 Xiaoyun Liu1,2,4,5 1Department of Neurology, The First Hospital of Hebei Medical University,
Chen R, Zhang K, Liu H, Liu L, Li H, Yan Y, Zhou Z, Meng C, Wang X, Wu H, Miao R, Wang R, Liu X   +12 more
doaj  

Lipoprotein a - Lp(a)

Indian Heart Journal
Lp(a) is a genetically determined, heritable, independent and causal risk factor for ASCVD. About 1 in 5 people worldwide have elevated Lp(a) (>50 mg/dL or >125 nmol/L) whereas in Indians it is 25 %. Epidemiological, genome-wide association and mendelian randomization studies have demonstrated an association between elevated Lp(a) levels and increased ...
openaire   +3 more sources

Consumption of a defined, plant‐based diet reduces lipoprotein(a), inflammation, and other atherogenic lipoproteins and particles within 4 weeks [PDF]

, 2018
Rami Najjar, Carolyn E. Moore, Baxter D. Montgomery   +2 more
openalex   +1 more source

Potent Liver‐Tropic mRNA Lipid Nanoparticles: ApoE‐Mediated Delivery Through a Low‐Density Lipoprotein Receptor Independent Uptake Mechanism

Advanced Materials, EarlyView.
Helper and ionizable lipids play a crucial role in determining ApoE binding and subsequent liver tropism and LDLR‐mediated uptake. Ionizable lipids primarily govern the LDLR‐independent uptake pathway. This complementary interplay between lipid components ultimately governs LNP delivery performance and therapeutic efficacy in the liver.
Ashish Sarode, Christian Ortiz, Tadeh Derstepanian, Natalia Vargas‐Montoya, Priyal Patel, Nikita Khadse, Saikat Manna, Ryan Landis, Joseph Skaleski, Lianne Boeglin, Hongfeng Deng, Anusha Dias, Hong Wang, Debora Barreiros Petropolis, Barak Yahalom, Shrirang Karve, Frank DeRosa   +16 more
wiley   +1 more source

Lipoproteína (a): estructura, metabolismo, genética y mecanismos patogénicos

Revista Cubana de Investigaciones Biomédicas, 2003
Se establecieron las características más sobresalientes de la lipoproteína (a), así como los mecanismos patogénicos de esta partícula lipoproteínica relacionados con la aterotrombogénesis.
Lázaro E. Alba Zayas, Giovanna Pereira Roca, Arístides Aguilar Betancourt   +2 more
doaj  

Lipoprotein(a) [PDF]

Clinical Research in Cardiology Supplements, 2019
K P, Mellwig, A, Vogt
openaire   +2 more sources